Investor
ACT CAPITAL MANAGEMENT, LLC
CIK 0001442273 · filed 2026-05-08 · SEC filing
13F book
$127.2M
Positions
56
20 new · 22 sold
Largest name
12.3%
Krystal Biotech, Inc. · KRYS
Est. mark
$6.33M
Price effect on 36 names still held. Flow −$2.76M.
| Name | Ticker | Shares | Value | Weight | Est. mark | Change |
|---|---|---|---|---|---|---|
| Krystal Biotech, Inc. | KRYS | 60.5K | $15.6M | 12.3% | $712.4K | Cut$706.7K |
| Chevron Corp New | CVX | 75K | $15.5M | 12.2% | $4.09M | Cut$3.55M |
| Exxon Mobil Corp | — | 70K | $11.9M | 9.3% | $3.45M | Cut$1.95M |
| Celcuity Inc. | CELC | 91.7K | $10.5M | 8.2% | $913.2K | Added$4.14M |
| Tg Therapeutics, Inc. | TGTX | 249K | $8.27M | 6.5% | $849.2K | Cut$257.4K |
| Abivax Sa | — | 70.9K | $7.89M | 6.2% | −$1.5M | Added−$722.5K |
| Amazon Com Inc | AMZN | 33K | $6.87M | 5.4% | −$554.7K | Added$1.19M |
| Viking Therapeutics, Inc. | VKTX | 209.3K | $6.81M | 5.4% | −$544.1K | Added−$440K |
| Arrowhead Pharmaceuticals In | — | 82.5K | $5.17M | 4.1% | −$276.7K | Added$193.5K |
| Nektar Therapeutics | NKTR | 70.9K | $5.1M | 4.0% | $1.52M | Added$2.94M |
| Cytokinetics Inc | CYTK | 64.5K | $4.25M | 3.3% | $152.9K | Held |
| Alumis Inc. | ALMS | 174.3K | $3.84M | 3.0% | — | New |
| Energy Transfer L P | — | 133.1K | $2.57M | 2.0% | $374K | Held |
| Freeport-Mcmoran Inc | FCX | 38.5K | $2.26M | 1.8% | — | New |
| Applied Optoelectronics, Inc. | AAOI | 25.9K | $2.19M | 1.7% | — | New |
| Xenon Pharmaceuticals Inc. | XENE | 33.5K | $1.95M | 1.5% | — | New |
| Nuvation Bio Inc. | NUVB | 290K | $1.24M | 1.0% | −$1.35M | Cut−$4.23M |
| Staar Surgical Co | STAA | 55.5K | $1.04M | 0.8% | −$243.6K | Held |
| Praxis Precision Medicines I | — | 2.7K | $869.9K | 0.7% | $19.2K | Added$663.6K |
| Grayscale Bitcoin Trust Etf | GBTC | 15.4K | $812.5K | 0.6% | −$240.2K | Cut−$1.54M |
| SentinelOne, Inc. | S | 54.3K | $699.4K | 0.5% | — | New |
| Lumentum Hldgs Inc | — | 900 | $632.5K | 0.5% | — | New |
| Bloom Energy Corp | BE | 4.5K | $609.7K | 0.5% | $218.7K | Cut−$519.9K |
| Crescent Energy Company | — | 45K | $607.5K | 0.5% | $229.9K | Cut$93.1K |
| Kura Oncology, Inc. | KURA | 73.9K | $600.8K | 0.5% | −$167K | Held |
| Vir Biotechnology, Inc. | VIR | 64.3K | $576.1K | 0.5% | — | New |
| Circle Internet Group, Inc. | CRCL | 6K | $572.5K | 0.4% | — | New |
| Warrior Met Coal, Inc. | HCC | 6K | $558.9K | 0.4% | $29.9K | Cut−$499.1K |
| UiPath, Inc. | PATH | 50K | $555K | 0.4% | −$248.6K | Added−$215.3K |
| Scholar Rock Hldg Corp | — | 10.8K | $530.9K | 0.4% | $55.2K | Cut$2.33K |
| GeneDx Holdings Corp. | WGS | 8K | $513.8K | 0.4% | −$197.5K | Added$123.6K |
| Micron Technology Inc | MU | 1.5K | $506.8K | 0.4% | — | New |
| Nvidia Corp | NVDA | 2.8K | $488.3K | 0.4% | — | New |
| Replimune Group, Inc. | REPL | 61.5K | $470.5K | 0.4% | −$127.3K | Held |
| REGENXBIO Inc. | RGNX | 56K | $469.3K | 0.4% | −$337.1K | Cut−$718.7K |
| Palisade Bio, Inc. | PALI | 257.5K | $450.6K | 0.4% | −$90K | Added$98.1K |
| Olema Pharmaceuticals, Inc. | OLMA | 25K | $372.8K | 0.3% | −$252.3K | Cut−$964.8K |
| Monte Rosa Therapeutics, Inc. | GLUE | 22.5K | $370.1K | 0.3% | — | New |
| Ondas Hldgs Inc | ONDS | 37.5K | $339K | 0.3% | — | New |
| Alpha Cognition Inc. | ACOG | 51.5K | $282.7K | 0.2% | −$52K | Held |
| MBX Biosciences, Inc. | MBX | 9K | $268.6K | 0.2% | — | New |
| Arko Pete Corp | — | 15K | $268.4K | 0.2% | — | New |
| Kyverna Therapeutics, Inc. | KYTX | 30K | $258.9K | 0.2% | −$19.3K | Added$23K |
| Ryerson Hldg Corp | — | 10.8K | $242.8K | 0.2% | — | New |
| Terra Innovatum Global Nv | — | 45K | $208.8K | 0.2% | $900 | Held |
| Incyte Corp | INCY | 2K | $188.2K | 0.1% | — | New |
| Capricor Therapeutics, Inc. | CAPR | 5K | $152K | 0.1% | $2.31K | Added$108.7K |
| Vishay Precision Group, Inc. | VPG | 3K | $130.3K | 0.1% | — | New |
| Esperion Therapeutics Inc Ne | — | 47.5K | $130.2K | 0.1% | −$45.6K | Held |
| Amylyx Pharmaceuticals, Inc. | AMLX | 9K | $125.1K | 0.1% | $16.4K | Held |
| Lightspeed Commerce Inc. | LSPD | 12.5K | $112K | 0.1% | −$39K | Held |
| Compass Pathways Plc | CMPS | 15.5K | $85.7K | 0.1% | — | New |
| Lantronix Inc | LTRX | 15K | $78.6K | 0.1% | — | New |
| Stratasys Ltd. | SSYS | 10K | $78.1K | 0.1% | −$8.7K | Held |
| Hims & Hers Health, Inc. | HIMS | 2.5K | $51.9K | 0.0% | — | New |
| Pds Biotechnology Corp | PDSB | 30K | $18.1K | 0.0% | −$4.94K | Held |
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.